Clinical Trial Update: A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis [Phase 2]

View source ↗

Summary

Phase II randomized, double-blind, cross-over study assessing safety, pharmacodynamics, and preliminary efficacy of GHRP-1/AG in patients with end-stage renal d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• GHRP-1/AG

Snippet

Sponsor: QLT Inc. | Conditions: End Stage Renal Disease | Phase 2 | Status: TERMINATED